Treating people with type 2 diabetes, also known as 'age-related diabetes' with antidiabetics reduces their risk for Alzheimer's and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. Researchers draw this conclusion from an analysis of health insurance data.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1CqRhrx
No comments:
Post a Comment